Muscle-Brain crosstalk in cognitive impairment
- PMID: 37577356
- PMCID: PMC10413125
- DOI: 10.3389/fnagi.2023.1221653
Muscle-Brain crosstalk in cognitive impairment
Abstract
Sarcopenia is an age-related, involuntary loss of skeletal muscle mass and strength. Alzheimer's disease (AD) is the most common cause of dementia in elderly adults. To date, no effective cures for sarcopenia and AD are available. Physical and cognitive impairments are two major causes of disability in the elderly population, which severely decrease their quality of life and increase their economic burden. Clinically, sarcopenia is strongly associated with AD. However, the underlying factors for this association remain unknown. Mechanistic studies on muscle-brain crosstalk during cognitive impairment might shed light on new insights and novel therapeutic approaches for combating cognitive decline and AD. In this review, we summarize the latest studies emphasizing the association between sarcopenia and cognitive impairment. The underlying mechanisms involved in muscle-brain crosstalk and the potential implications of such crosstalk are discussed. Finally, future directions for drug development to improve age-related cognitive impairment and AD-related cognitive dysfunction are also explored.
Keywords: Alzheimer's disease; aging; cognitive impairment; sarcopenia; skeletal muscle.
Copyright © 2023 Han, Ashraf, Tipparaju and Xuan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
